To date there has been no documented or published research conducted on the use of PCT agents on females for the purpose of restoring normal hormone function following a female anabolic steroid cycle . Anecdotal evidence tells us that very few females within the anabolic steroid using community engage in PCT protocols following the conclusion of anabolic steroid cycles. Logic should also tell us that females should not require PCT protocols, as the purpose of a PCT protocol is done so as to restore the HPTA (hypothalamic pituitary testicular axis) in male anabolic steroid users. It stands to reason that females do not possess testicles, and do not have any requirement for the restoration of Testosterone levels to any levels above a bare minimum trace after an anabolic steroid cycle. PCT medications such as Tamoxifen ( Nolvadex ), Clomiphene (Clomid), HCG (human chorionic gonadotropin ), Arimidex (Anastrozole), Aromasin (Exemestane), and the whole plethora of other related compounds were originally developed and used to fight female breast cancer. While mostly beneficial for males in the restoration of the HPTA, there is not only no need for females to use these compounds, but the use of these compounds can and will result in a further disruption of normal hormonal function and many of them are also associated with a significant number of detrimental, uncomfortable, and inconvenient side effects in females.
The two steroids are really interchangeable, and cypionate is not at all superior. Both are long acting oil-based injectables, which will keep testosterone levels sufficiently elevated for approximately two weeks. Enanthate may be slightly better in terms of testosterone release, as this ester is one carbon atom lighter than cypionate (remember the ester is calculated in the steroids total milligram weight). The difference is so insignificant however that no one can rightly claim it to be noticeable (we are maybe talking a few milligrams per shot).